pH manipulation as a novel strategy for treating mucormycosis

Wioleta J Trzaska1, Joao N Correia2, Maria T Villegas2

  • 1Institute of Microbiology and Infection and School of Biosciences, University of Birmingham, Birmingham, United Kingdom NIHR Surgical Reconstruction and Microbiology Research Centre, University Hospitals of Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.

Insights

Acetic acid shows high efficacy against Mucorales, the fungi causing mucormycosis. This dilute acid may offer a safe, low-cost prophylactic treatment for traumatic injury patients at risk of this fungal infection.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Biochemistry

Background:

  • Mucormycosis is a fatal fungal infection caused by Mucorales.
  • Traumatic injury is an emerging risk factor for mucormycosis.
  • Current treatments are often ineffective, costly, and require surgery.

Purpose of the Study:

  • To evaluate acetic acid as a potential prophylactic treatment for mucormycosis.
  • To investigate the mechanism of acetic acid's antifungal activity against Mucorales.

Main Methods:

  • Testing the efficacy of various concentrations of acetic acid against pathogenic Mucorales.
  • Comparing acetic acid's activity to other acids (hydrochloric, lactic).
  • Investigating the role of intracellular pH and pH-independent toxicity.

Main Results:

  • Acetic acid demonstrated high efficacy against Mucorales at low concentrations (0.3%).
  • Other acids did not show similar antifungal effects.
  • Acetic acid's activity is attributed to both intracellular pH reduction and pH-independent toxicity.

Conclusions:

  • Dilute acetic acid is a potent antifungal agent against Mucorales.
  • Acetic acid presents a potential low-cost, safe prophylactic treatment for mucormycosis in high-risk patients.
  • Further research is warranted to explore its clinical application in traumatic injury settings.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
62
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
2.1K
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
52